Medical devices firm Micro Life Sciences (Meril) on Monday said a wholly owned subsidiary of Abu Dhabi Investment Authority (ADIA) has entered into definitive agreements to invest $200 million for around 3% stake in the company.
The investment values Meril at an enterprise value of $6.6 billion. Post the investment, Meril will be backed by two globally recognised investors – ADIA and Warburg Pincus. The transaction is subject to regulatory approval by the Competition Commission of India (CCI), the company said in a release.
“This investment will enable us to accelerate growth, attract world-class talent and further strengthen our R&D and clinical research efforts,” Senior Vice President – Strategy Sanjeev Bhatt said.
Established by Bilakhia Group and headquartered in Vapi, Gujarat, Meril operates vertically integrated and globally certified manufacturing and research and development facilities across a 100 acre medtech campus. The company said it employs more than 13,000 people and 35 global subsidiaries and focused on clinically advanced solutions across multiple specialties, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics.
Published – July 21, 2025 09:30 pm IST